OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE – COALITION VIII randomised clinical trial
Álvaro Avezum, Haliton Alves de Oliveira, Precil Diego Miranda de Menezes Neves, et al.
EClinicalMedicine (2023) Vol. 60, pp. 102004-102004
Open Access | Times Cited: 11
Álvaro Avezum, Haliton Alves de Oliveira, Precil Diego Miranda de Menezes Neves, et al.
EClinicalMedicine (2023) Vol. 60, pp. 102004-102004
Open Access | Times Cited: 11
Showing 11 citing articles:
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
Sam Schulman, Donald M. Arnold, Charlotte Bradbury, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 6, pp. 1779-1797
Open Access | Times Cited: 18
Sam Schulman, Donald M. Arnold, Charlotte Bradbury, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 6, pp. 1779-1797
Open Access | Times Cited: 18
Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
Thromboprophylaxis for outpatients with COVID-19: a Systematic Review and Meta-analysis
Cho‐Han Chiang, Omer Ahmed, Weitao Liu, et al.
Journal of Thrombosis and Thrombolysis (2024) Vol. 57, Iss. 5, pp. 784-787
Closed Access | Times Cited: 1
Cho‐Han Chiang, Omer Ahmed, Weitao Liu, et al.
Journal of Thrombosis and Thrombolysis (2024) Vol. 57, Iss. 5, pp. 784-787
Closed Access | Times Cited: 1
Incidence and individual risk prediction of post-COVID-19 cardiovascular disease in the general population: a multivariable prediction model development and validation study
Hannah M la Roi-Teeuw, Maarten van Smeden, Geert‐Jan Geersing, et al.
European Heart Journal Open (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 3
Hannah M la Roi-Teeuw, Maarten van Smeden, Geert‐Jan Geersing, et al.
European Heart Journal Open (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 3
O uso dos Anticoagulantes Orais de Ação Direta (DOACs) como terapia anticoagulante na COVID-19
Eduardo Macedo Sousa, Gustavo Elias Ferreira Neto, Henrique Moura Lobo, et al.
Revista Eletrônica Acervo Saúde (2024) Vol. 24, Iss. 2, pp. e14951-e14951
Open Access
Eduardo Macedo Sousa, Gustavo Elias Ferreira Neto, Henrique Moura Lobo, et al.
Revista Eletrônica Acervo Saúde (2024) Vol. 24, Iss. 2, pp. e14951-e14951
Open Access
Effectiveness and safety of rivaroxaban for anticoagulation therapy in COVID-19
X. Shen, Eryue Qiu, Zhao Liu, et al.
Saudi Medical Journal (2024) Vol. 45, Iss. 4, pp. 341-348
Open Access
X. Shen, Eryue Qiu, Zhao Liu, et al.
Saudi Medical Journal (2024) Vol. 45, Iss. 4, pp. 341-348
Open Access
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs. no anticoagulation: Final analysis of the OVID randomized trial
Riccardo M. Fumagalli, Davide Voci, Behnood Bikdeli, et al.
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 8, Iss. 5, pp. 102534-102534
Open Access
Riccardo M. Fumagalli, Davide Voci, Behnood Bikdeli, et al.
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 8, Iss. 5, pp. 102534-102534
Open Access
Primary thromboprophylaxis in ambulatory symptomatic patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
Davide Di Vece, Marco Valgimigli, Elliot S. Barnathan, et al.
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 8, Iss. 8, pp. 102613-102613
Open Access
Davide Di Vece, Marco Valgimigli, Elliot S. Barnathan, et al.
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 8, Iss. 8, pp. 102613-102613
Open Access
Prophylactic-dose direct oral anticoagulants for non-hospitalised people with COVID-19: A meta-analysis of randomised controlled trials
Qingchun Song, Hongduan Liu, Haoyu Tan, et al.
Journal of Global Health (2024) Vol. 14
Open Access
Qingchun Song, Hongduan Liu, Haoyu Tan, et al.
Journal of Global Health (2024) Vol. 14
Open Access
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials
Judith Hsia, Alex C. Spyropoulos, Gregory Piazza, et al.
Thrombosis and Haemostasis (2023) Vol. 124, Iss. 07, pp. 649-655
Open Access | Times Cited: 1
Judith Hsia, Alex C. Spyropoulos, Gregory Piazza, et al.
Thrombosis and Haemostasis (2023) Vol. 124, Iss. 07, pp. 649-655
Open Access | Times Cited: 1
Rivaroxaban Plasma Concentration and Clinical Outcomes on Older Patients with Non-valvular Atrial Fibrillation and Pulmonary Infection
Yan Yu, Haobin Li, Jing Liu, et al.
American Journal of Cardiovascular Drugs (2023)
Closed Access
Yan Yu, Haobin Li, Jing Liu, et al.
American Journal of Cardiovascular Drugs (2023)
Closed Access
